This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.
Cronos Group Shares Rise On Strong Q1 Earnings, $50M Share Buyback: Retail Sentiment Soars Despite facing potential tariffs on its cannabis imports to Israel, retail sentiment surged, reflecting optimism around the company’s performance and future growth prospects.
Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year' Cronos reported first-quarter revenue of $32.26 million, beating analyst estimates of $31.70 million, according to Benzinga Pro. The company reported first-quarter earnings of 2 cents per share, beating estimates for a loss of 1 cent per share.
The Canadian Cannabis Report - Monday, April 28 The past, present, and future of the Canadian cannabis sector.
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp' Cannabis stocks jumped as Trump reportedly pushes SAFE Banking behind the scenes—but analysts warn: don't chase the hype just yet.
The Canadian Cannabis Report- Mondaty April 21 The past, present, and future of the Canadian cannabis sector.
The Canasian Cannabis Report- Monday, April 14 The past, present and futur eof the Canasian cannabis sector.
The Canadian Cannabis Report- Monday, April 7 The past, present, and future of the Canadian cannabis sector.
The Canadian Cannabis Report - Monday, March 31 The past, present, and future of the Canadian cannabis sector.
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis.
